Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41447
Submission : 2025-03-06
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13102
Submission : 1998-07-29
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14644
Submission : 1999-12-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15909
Submission : 2001-12-21
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15916
Submission : 2002-03-29
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16284
Submission : 2002-12-02
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16285
Submission : 2002-12-02
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18730
Submission : 2005-09-06
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16066
Submission : 2002-07-10
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21599
Submission : 2008-05-06
Status : Inactive
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41447
Submission : 2025-03-06
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18730
Submission : 2005-09-06
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16066
Submission : 2002-07-10
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14644
Submission : 1999-12-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16285
Submission : 2002-12-02
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15916
Submission : 2002-03-29
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13102
Submission : 1998-07-29
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16284
Submission : 2002-12-02
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15909
Submission : 2001-12-21
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21014
Submission : 2007-11-02
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : GLYCOPYRROLATE
Dosage Form : TABLET; ORAL
Application Number : 91522
Country : US
Patented : No
Drug : TIZANIDINE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 76286
Country : US
Patented : No
Drug : ERRIN
Dosage Form : TABLET; ORAL-28
Application Number : 76225
Country : US
Patented : No
Drug : CAPECITABINE
Dosage Form : TABLET; ORAL
Application Number : 204345
Country : US
Patented : No
Drug : DIAZEPAM
Dosage Form : TABLET; ORAL
Application Number : 71136
Country : US
Patented : No
DROSPIRENONE; ETHINYL ESTRADIOL
Drug : DROSPIRENONE AND ETHINYL ESTRADIOL
Dosage Form : TABLET; ORAL-28
Application Number : 90081
Country : US
Patented : No
Drug : DIAZEPAM
Dosage Form : TABLET; ORAL
Application Number : 71135
Country : US
Patented : No
ETHINYL ESTRADIOL; LEVONORGESTREL
Drug : LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL
Dosage Form : TABLET; ORAL
Application Number : 78834
Country : US
Patented : No
Drug : DIAZEPAM
Dosage Form : TABLET; ORAL
Application Number : 71134
Country : US
Patented : No
Drug : ZIPRASIDONE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77565
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ANHYDROUS LACTOSE
Route : BUCCAL
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 23.75
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : IM - IV
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 2.5
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : IM - IV
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 2.5
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : INTRACAVITARY
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 4.75
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : INTRAVENOUS
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 28.75
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : IV(INFUSION)
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 2.5
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 46.06
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 71.91
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 40
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63-42-3
UNII : 3SY5LH9PMK
Potency Amount : 117
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
Application : Direct Compression
Pharmacopoeia Ref : Conforms to Ph. Eur., Lactose ...
Technical Specs : Density- Tapped density- 906 g/l, Bulk density- 722 g/l; Particle...
Ingredient(s) : Anhydrous Lactose
Brand Name : Microlex® LCA 60.m
Application : Direct Compression
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 20...
Ingredient(s) : Anhydrous Lactose
Brand Name : Sheffield™ Anhydrous 60M
Application : Direct Compression
Excipient Details : Direct Compression & Granulation
Brand Name : Sheffield™ Anhydrous DT
Application : Direct Compression
Excipient Details : Direct Compression
Brand Name : Sheffield™ Anhydrous DTHV-I
Application : Direct Compression
Excipient Details : Direct Compression
Brand Name : Sheffield™ Anhydrous Impalpable
Application : Direct Compression
Excipient Details : Direct Compression & Granulation
Brand Name : Microlex® LCA 60.m
Application : Granulation
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 20...
Ingredient(s) : Anhydrous Lactose
Brand Name : Sheffield™ Anhydrous 60M
Application : Granulation
Excipient Details : Direct Compression & Granulation
Brand Name : Sheffield™ Anhydrous Impalpable
Application : Granulation
Excipient Details : Direct Compression & Granulation
MARKET PLACE
REF. STANDARDS & IMPURITIES